ArticleLife (Basel, Switzerland)2023

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer's Disease.

Kyriaki Savva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.